Applicant profile
ENGAIN CO.,Ltd
ENGAIN CO.,Ltd
Hong Kong MDACS·South Korea·1 registered device·May 08, 2024 – May 08, 2024
1
Total devices
1
Risk classes
2024
First registration
2024
Most recent
Applicant overview
Bilingual manufacturer details sourced from Hong Kong MDACS
- Applicant (EN)
- ENGAIN CO.,Ltd
- Applicant (ZH)
- ENGAIN CO.,Ltd
- Country
- South Korea韩国
- Address
- B153, B162, B163, B173, B174 and B175, The First Tower, 10, Dongtan-daero 21-gil, Hwaseong-si, Gyeonggi-do, 18471, Republic of KoreaB153、B162、B163、B173、B174 和 B175, The First Tower, 10, Dongtan-daero 21-gil, Hwaseong-si, Gyeonggi-do, 18471, Republic of Korea
Timeline
- First registration
- May 08, 2024
- Most recent
- May 08, 2024
Risk class breakdown
IV
1
Recent MDACS registrations
Latest 15 devices linked to this applicant
| Device | Risk class | Authorised rep | Registered |
|---|---|---|---|
| Occluders, Vascular, Intravascular Embolization, Particulate 封堵器、血管、血管内栓塞、微粒 | IV | Transmedic China Limited | May 08, 2024 |
About this profile
ENGAIN CO.,Ltd is associated with 1 medical device registered under the Hong Kong Medical Device Administrative Control System (MDACS). Explore bilingual product names, risk classes, authorised representatives, and life-cycle milestones.